There are options for overactive bladder treatment that don't require surgery or drug therapy. One example of this is called OAB behavioral modification, and more specifically the alteration in fluid intake. It is not recommended that you dehydrate yourself, but rather a moderation in fluid intake.
Another example of behavioral modification is training your bladder. For this, you would go to the bathroom on a schedule, or you could do what you call Kegel exercises, which is to essentially contract the muscles of the pelvic floor to strengthen the muscle.
In this episode of Health Insights, Dr. Holly Atkinson sits down with Dr. Harris Foster to discuss overactive bladder and how behavioral therapy can dramatically change how you feel. It's worth trying a number of techniques to find the right one or combination that works best for you.
Apostolidis A. Neuromodulation for intractable OAB. Neurourol Urodyn 2011;30(50):766-70.
Athanasopoulos A, Chapple C, Fowler C, Gratzke C, Kaplan S, Stief C, Tubaro A. The role of antimuscarinics in the management of men with symptoms of overactive bladder associated with concomitant bladder outlet obstruction: an update.Eur Urol 2011;60(1):94-105. Epub 2011 Apr 9.
Carr LK. Botulinum toxin A should not be first-line therapy for overactive bladder. Can Urol Assoc J 2011;5(3):204-5.
Dmochowski RR, Gomelsky A.Update on the treatment of overactive bladder. Curr Opin Urol 2011;21(4):286-90.
Heidler S, Mert C, Temml C, Madersbacher S. The natural history of the overactive bladder syndrome in females: A long-term analysis of a health screening project. Neurourol Urodyn 2011, Jun 9. [Epub ahead of print]
Robinson D, Cardozo L. Estrogens and the lower urinary tract. Neurourol Urodyn 2011;30(50):754-7.
Schnitzler A, Genet F, Durand MC, Roche N, Bensmail D, Chartier-Kastler E, Denys P.Pilot study evaluating the safety of intradetrusor injections of botulinum toxin type A: Investigation of generalized spread using single-fiber EMG.Neurourol Urodyn 2011, Jun 9. doi: 10.1002/nau.21103. [Epub ahead of print]
Sexton CC, Notte SM, Maroulis C, Dmochowski RR, Cardozo L, Subramanian D, Coyne KS.Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature. Int J Clin Pract 2011;65(5):567-85.
Weiss JP, Blaivas JG, Bliwise DL, Dmochowski RR, Dubeau CE, Lowe FC, Petrou SP, Van Kerrebroeck PE , Rosen RC, Wein AJ. The evaluation and treatment of nocturia: a consensus statement.BJU Int 2011;108(1):6-21.